Spot on! But I noticed your cautious approach and reassurance of excitement all along! haha!
-
-
-
It's my brand

- Show replies
New conversation -
-
-
I don't think they only check at 1 week after second dose whether patient was infected. It's stated in the protocol at each visit (for 2 years) that blood will be collected for immunogenicity testing. In fact, I believe that only infections after visit 5 count for the study.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
If annual boosters are required, might it be possible to combine this with the flu shot (ideally in one shot)?
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
I seen a few mention the temperature. Could that be an added issue?
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
You got an important point wrong. All the cases were symptomatic - participants only got tested if they reported symptoms.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
It’s a very good post. From what I have understood, none of the current phase III trials is focusing on the issues you highlighted - prevention of severe disease or interruption of the transmission. Is that right?
-
No that's not quite correct. They mostly use prevention of disease as their PRIMARY endpoint, and that's all that they can statistically demonstrate so far, but with the FULL numbers in the trials it should be possible to assess things like severe disease
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.